Sharon Hemond Hrynkow, Chief Scientific Officer at Cyclo Therapeutics, Inc. (CYTH), bought 1,000 shares at $7.46 ($7K) on 2021-03-29, disclosed to the SEC on 2021-03-30.
Open-market purchase of $7k CYTH by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CTDH | BUY | 2019-08-02 | $2K | — | Filing → |
| CTDH | BUY | 2019-07-31 | $2K | — | Filing → |